ARCHIVES

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Six More CCOPS In Funding Range For Recompetition

February 9, 1990

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

DCT Board Approves Concept of New Programs, Including “Task Order”

November 2, 1979

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

July 11, 2014

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013

House Plan Promises $3.5 Billion For NIH; Cooperative Groups May Get AHRQ Funds

January 23, 2009